Evista combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Toe Amputation Hospitalization 7/1/2005 Female 161 lb 1/4/2006 Physician United States
Primary
Secondary
Concomitant
Retinal Vascular Thrombosis Other Serious 6/16/2002 57 Female 181 lb 1/17/2006 Lawyer United States
Primary
Concomitant
Ventricular Hypokinesia Hospitalization 3/9/2004 59 Female 165 lb 1/18/2006 Physician United States
Primary
Concomitant
Retinal Vein Occlusion Other Serious 3/12/2002 57 Female 181 lb 1/24/2006 Physician United States
Primary
Concomitant
Transient Ischaemic Attack Other Serious 5/17/2001 67 Female 108 lb 1/30/2006 Physician United States
Primary
Concomitant
Wrong Drug Administered Other Serious 8/23/2003 58 Female 195 lb 2/3/2006 United States
Primary
Secondary
Concomitant
Myocardial Infarction Other Serious 5/1/2002 46 Female 150 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Urticaria Other Serious 1/1/2002 79 Female 1/30/2006 United States
Primary
Secondary
Concomitant
Vertigo Other Serious 3/1/2000 Female 240 lb 2/23/2006 Lawyer United States
Primary
Concomitant
Ovarian Cancer Other Serious 1/1/1995 40 Female 160 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Osteoporosis Hospitalization 1/1/2000 Female 126 lb 2/27/2006 Lawyer United States
Primary
Concomitant
Vertigo Hospitalization 4/10/2001 65 Female 152 lb 2/28/2006 Physician United States
Primary
Concomitant
Skin Papilloma Hospitalization 1/1/2000 Female 126 lb 3/1/2006 Physician United States
Primary
Concomitant
Ovarian Cancer Other Serious 8/1/1996 51 Female 207 lb 3/1/2006 United States
Primary
Secondary
Vertigo Other Serious 3/1/2000 Female 240 lb 3/17/2006 Physician United States
Primary
Concomitant
Weight Increased 1/27/1994 55 Female 173 lb 3/10/2006 Lawyer United States
Primary
Secondary
Concomitant
Ventricular Hypokinesia Hospitalization 3/9/2004 59 Female 165 lb 4/3/2006 Physician United States
Primary
Concomitant
Weight Increased 1/27/1994 55 Female 173 lb 3/29/2006 Lawyer United States
Primary
Secondary
Concomitant
Visual Acuity Reduced Other Serious 1/1/2002 79 Female 110 lb 11/4/2005 United States
Primary
Secondary
Concomitant
Ventricular Hypokinesia Hospitalization 3/9/2004 59 Female 165 lb 4/21/2006 Physician United States
Primary
Concomitant
Ventricular Hypertrophy Other Serious 3/12/2002 57 Female 181 lb 4/21/2006 Physician United States
Primary
Concomitant
Visual Disturbance Other Serious 3/12/2002 57 Female 181 lb 4/24/2006 Physician United States
Primary
Concomitant
Pernicious Anaemia Hospitalization 7/8/2001 79 Female 126 lb 4/25/2006 Physician United States
Primary
Concomitant
Ventricular Hypokinesia Hospitalization 3/9/2004 59 Female 165 lb 5/1/2006 Physician United States
Primary
Concomitant
Therapy Non-responder Hospitalization 1/1/2000 70 Female 126 lb 5/2/2006 Physician United States
Primary
Concomitant
Retinal Vein Occlusion Other Serious 3/12/2002 57 Female 181 lb 5/5/2006 Physician United States
Primary
Concomitant
Vertigo Hospitalization 4/10/2001 65 Female 152 lb 5/15/2006 Physician United States
Primary
Concomitant
Ventricular Hypokinesia Hospitalization 3/9/2004 59 Female 165 lb 5/18/2006 Physician United States
Primary
Concomitant
Weight Increased 1/27/1994 55 Female 173 lb 5/22/2006 Lawyer United States
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 4/10/2006 46 Female 5/26/2006 Consumer United States
Primary
Secondary
Concomitant
Vomiting Other Serious 4/10/2006 46 Female 7/28/2006 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2000 75 Female 150 lb 8/17/2006 Consumer United States
Primary
Secondary
Colonic Obstruction Hospitalization 82 Female 8/15/2006 Consumer United States
Primary
Concomitant
Breast Cancer Other Serious 5/1/2000 75 Female 150 lb 11/13/2006 Consumer United States
Primary
Secondary
Myocardial Infarction Other Serious 1/1/1999 Female 200 lb 11/29/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/9/2000 75 Female 150 lb 12/5/2006 Consumer United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 1/1/1999 Female 200 lb 12/11/2006 United States
Primary
Secondary
Concomitant
Inappropriate Schedule Of Drug Administration Hospitalization 1/1/1986 62 Female 145 lb 10/10/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Hospitalization 12/30/2002 Female 175 lb 2/27/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Swelling Other Serious 1/26/2006 76 Female 158 lb 12/14/2006 Physician United States
Primary
Concomitant
Uterine Leiomyoma Other Serious 8/6/1998 59 Female 130 lb 4/20/2007 United States
Primary
Secondary
Concomitant
Headache Hospitalization 2/23/2007 62 Female 4/26/2007 United States
Primary
Concomitant
Headache Hospitalization 2/23/2007 62 Female 4/26/2007 United States
Primary
Concomitant
Headache Hospitalization 2/23/2007 62 Female 5/5/2007 United States
Primary
Concomitant
Weight Loss Poor Hospitalization 69 Female 271 lb 6/21/2007 Consumer United States
Primary
Secondary
Concomitant
Thrombosis Hospitalization 1/1/2005 74 Female 8/22/2007 Consumer
Primary
Concomitant
Phlebitis Superficial Other Serious 8/25/2007 63 Female 165 lb 8/31/2007 Other Health Professional Puerto Rico
Primary
Concomitant
Ovarian Cancer Other Serious 9/9/1996 Female 207 lb 10/4/2007 Consumer United States
Primary
Secondary
Pruritus 10/1/2006 59 Female 10/25/2007 Consumer United States
Primary
Concomitant
Uterine Leiomyoma Other Serious 8/6/1998 11/15/2007 United States
Primary
Secondary
Concomitant
Sleep Apnoea Syndrome Other Serious 12/1/2006 Female 152 lb 2/22/2008 Consumer United States
Primary
Concomitant
Urinary Tract Infection Other Serious 1/1/2003 63 Female 2/29/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Varicose Vein Other Serious 9/2/2007 90 Female 12/13/2007 Physician United States
Primary
Concomitant
Phlebitis Superficial Other Serious 8/25/2007 64 Female 165 lb 3/25/2008 Other Health Professional Puerto Rico
Primary
Concomitant
Vulvovaginal Dryness Other Serious 1/1/1995 4/23/2008 United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 12/1/1998 Female 5/5/2008 Consumer United States
Primary
Secondary
Retinal Haemorrhage Other Serious 1/1/2008 Female 6/4/2008 Consumer United States
Primary
Concomitant
Stent Placement Other Serious 6/1/1998 Female 6/23/2008 Consumer United States
Primary
Concomitant
Vomiting Other Serious Female 7/9/2008 Consumer United States
Primary
Interacting
Vomiting Other Serious Female 9/8/2008 Consumer United States
Primary
Interacting
Breast Cancer Metastatic Other Serious 9/17/2003 Female 11/10/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 75 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/12/1995 49 Female 200 lb 10/9/2008 Consumer United States
Primary
Secondary
Pain In Extremity Other Serious 7/2/2001 67 Female 118 lb 10/27/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/27/2000 57 Female 12/19/2008 United States
Primary
Secondary
Renal Cyst Other Serious 6/27/1996 Female 135 lb 2/4/2009 United States
Primary
Secondary
Concomitant
Vomiting Other Serious 11/19/2002 Female 128 lb 2/6/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/1/2001 72 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/10/2000 62 Female 12/19/2008 United States
Primary
Secondary
Wheelchair User Other Serious 1/1/1998 Female 3/18/2009 Physician United States
Primary
Concomitant
Breast Cancer Female Other Serious 5/1/2000 Female 3/24/2009 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 12/1/1998 Female 3/30/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/28/2002 Female 150 lb 3/30/2009 Lawyer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/22/2002 Female 4/21/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/3/2001 Female 4/29/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/8/2003 Female 180 lb 4/30/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/28/2004 Female 5/6/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2000 Female 225 lb 5/12/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 5/8/2002 Female 5/15/2009 Lawyer United States
Primary
Secondary
Ventricular Extrasystoles Hospitalization 3/5/2009 56 Female 5/27/2009 United States
Primary
Concomitant
Breast Cancer Female Other Serious 9/9/2004 Female 146 lb 6/8/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/1/1996 Female 6/10/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2000 Female 115 lb 6/10/2009 United States
Primary
Secondary
Concomitant
Vomiting Other Serious 6/4/2009 53 Female 150 lb 6/6/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2001 Female 6/15/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/8/1999 Female 150 lb 6/24/2009 Lawyer United States
Primary
Secondary
Concomitant
Vulvovaginal Candidiasis Other Serious 11/19/2002 Female 128 lb 7/8/2009 Other Health Professional United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 5/8/2002 Female 8/19/2009 Lawyer United States
Primary
Secondary
Nausea 5/17/2009 Female 135 lb 8/22/2009 United States
Primary
Concomitant
Vulvovaginal Candidiasis Other Serious 11/19/2002 Female 128 lb 9/1/2009 United States
Primary
Secondary
Concomitant
Drug Intolerance 80 Female 9/16/2009 Consumer United States
Primary
Concomitant
Breast Cancer Female Other Serious 6/1/2003 Female 150 lb 9/30/2009 Consumer United States
Primary
Secondary
Concomitant
Parosmia Hospitalization 1/1/2008 75 Female 212 lb 12/2/2009 Consumer United States
Primary
Concomitant
Renal Cyst Other Serious 6/27/1996 Female 135 lb 12/9/2009 United States
Primary
Secondary
Concomitant
Vulvovaginal Candidiasis Other Serious 11/19/2002 Female 128 lb 12/15/2009 United States
Primary
Secondary
Concomitant
Vulvovaginal Candidiasis Other Serious 11/19/2002 Female 128 lb 1/26/2010 United States
Primary
Secondary
Concomitant
Respiratory Disorder Other Serious 1/1/2007 Female 150 lb 1/30/2010 United States
Primary
Concomitant
Vitamin D Decreased Hospitalization 1/1/2008 Female 2/8/2010 Consumer United States
Primary
Secondary
Concomitant
Parosmia Hospitalization 1/1/2008 75 Female 212 lb 2/11/2010 Consumer United States
Primary
Concomitant
Vulvovaginal Candidiasis Other Serious 11/19/2002 Female 128 lb 3/11/2010 United States
Primary
Secondary
Concomitant
Spinal Cord Disorder Other Serious 1/1/1997 Female 105 lb 3/26/2010 United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2/8/2002 60 Female 120 lb 4/6/2010 Physician United States
Primary
Concomitant
Spinal Cord Disorder Other Serious 1/1/1997 53 Female 105 lb 4/6/2010 France
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 2/8/2002 60 Female 120 lb 4/15/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Breast Cancer Stage Ii Other Serious 6/9/2003 58 Female 150 lb 4/29/2010 Lawyer United States
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 2/8/2002 60 Female 120 lb 4/29/2010 United States
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 2/8/2002 60 Female 120 lb 5/7/2010 United States
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 2/8/2002 60 Female 120 lb 5/19/2010 United States
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 2/8/2002 60 Female 120 lb 5/21/2010 United States
Primary
Secondary
Concomitant
Malabsorption Other Serious Female 5/28/2010 Physician United States
Primary
Concomitant
Breast Cancer Female Other Serious 9/1/1995 51 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/9/2000 62 Female 181 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 9/1/1995 51 Female 6/24/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/8/1999 57 Female 150 lb 6/24/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/1/2001 72 Female 181 lb 4/5/2010 United States
Primary
Secondary
Endometrial Neoplasm Other Serious 5/1/2010 63 Female 140 lb 7/2/2010 Consumer United States
Primary
Concomitant
Breast Cancer Female Other Serious 12/1/2006 72 Female 141 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/28/2004 57 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 6/1/2002 58 Female 141 lb 4/5/2010 United States
Primary
Secondary
White Blood Cell Count Increased Other Serious 2/8/2002 60 Female 120 lb 7/15/2010 United States
Primary
Secondary
Concomitant
Weight Increased 7/16/2007 54 Female 145 lb 7/15/2010 Consumer United States
Primary
Concomitant
Breast Cancer Other Serious 12/1/2003 64 Female 165 lb 5/19/2010 Consumer United States
Primary
Secondary
Concomitant
Oesophageal Hypomotility Hospitalization Female 118 lb 8/25/2010 Other Health Professional United States
Primary
Concomitant
Nausea 5/17/2009 75 Female 144 lb 8/29/2010 Consumer United States
Primary
Concomitant
Spinal Osteoarthritis Other Serious 7/1/1996 49 Female 135 lb 9/6/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/9/2004 59 Female 9/17/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/15/2002 69 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/19/2004 58 Female 9/23/2010 Lawyer United States
Primary
Secondary
Thrombosis Other Serious 1/1/1998 47 Female 290 lb 9/23/2010 Consumer United States
Primary
Secondary
Throat Irritation 80 Female 10/27/2010 Other Health Professional United States
Primary
Concomitant
Breast Cancer Other Serious 3/12/1995 49 Female 200 lb 10/12/2010 United States
Primary
Secondary
Endometrial Cancer Other Serious 5/1/2010 63 Female 140 lb 10/12/2010 United States
Primary
Secondary
Death Death 4/27/2007 12/6/2010 Physician United States
Primary
Concomitant
Myocardial Infarction Hospitalization 6/18/2003 66 Female 203 lb 1/26/2011 Lawyer United States
Primary
Secondary
Onychomycosis Other Serious 1/22/2005 63 Female 113 lb 3/11/2011 Pharmacist United States
Primary
Secondary
Concomitant
Tongue Biting Disability 1/1/1990 49 Female 160 lb 2/28/2011 Lawyer United States
Primary
Concomitant
Urticaria Other Serious Female 3/15/2011 Consumer United States
Primary
Secondary
Hernia Other Serious 1/1/2002 Female 3/20/2011 Consumer United States
Primary
Secondary
Dry Eye 3/1/2011 54 Female 108 lb 4/12/2011 Consumer United States
Primary
Secondary
Concomitant
Haematoma Other Serious 1/22/2005 63 Female 113 lb 4/18/2011 United States
Primary
Secondary
Concomitant
Multi-organ Failure Other Serious 9/1/2003 68 Female 180 lb 4/21/2011 Consumer United States
Primary
Concomitant
Night Sweats Other Serious 1/1/2002 Female 4/22/2011 Physician United States
Primary
Secondary
Cerebral Atrophy Other Serious 1/22/2005 63 Female 113 lb 5/2/2011 Physician United States
Primary
Secondary
Concomitant
Hip Arthroplasty Other Serious 7/1/2010 70 Female 119 lb 5/12/2011 Physician United States
Primary
Concomitant
Breast Cancer Female Other Serious 1/1/2001 58 Female 5/24/2011 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/27/2000 58 Female 5/23/2011 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/27/2000 58 Female 5/26/2011 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/21/2001 54 Female 249 lb 5/27/2011 Lawyer United States
Primary
Secondary
Concomitant
Compression Fracture Other Serious 2/8/2002 60 Female 120 lb 6/10/2011 Other Health Professional United States
Primary
Secondary
Concomitant
Cough Other Serious 2/8/2002 60 Female 120 lb 6/28/2011 Other Health Professional United States
Primary
Secondary
Concomitant

Drug Data